During the past decade, Frenchay Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frenchay Hospital" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Genzyme, a Sanofi Company" with 2 trials sponsored, "Queen Mary University of London" with 2 trials sponsored, "Anglo Celtic Cooperative Oncology Group" with 1 trials sponsored and "Biosensors Europe SA" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frenchay Hospital" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Cancer Research UK" with 2 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator, "Global Research Solutions" with 1 trials as a collaborator and "Hull University Teaching Hospitals NHS Trust" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Frenchay Hospital" are "Breast Cancer" (3 trials), "Idiopathic Parkinson's Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Back Pain" (1 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "Frenchay Hospital" in a lesser frequency.

Most popular intervention types in "Frenchay Hospital" are "Drug" (8 trials), "Procedure" (4 trials), "Biological" (3 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "0.9% Normal Saline" (1 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Frenchay Hospital" are 13 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Frenchay Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Frenchay Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Frenchay Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".